After 90 days, MPO levels declined further (188.4 ng/ml [108.6–395.3 ng/ml]; p < 0.001); however, this decrease did not reach statistical significance compared to the data obtained after 30 days.
← all excerpts
Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response.
1
—
—